Effect of Single-Dose Rituximab on Primary Glomerular Diseases-Reference-Cited by-同舟云学术

Effect of Single-Dose Rituximab on Primary Glomerular Diseases

Published:2011 Issue:2 Volume:117 Page:c98-c105
ISSN:1660-2110
Container-title:Nephron Clinical Practice
language:en
Short-container-title:Nephron Clin Pract

Author:

Sugiura Hidekazu,Takei Takashi,Itabashi Mitsuyo,Tsukada Misao,Moriyama Takahito,Kojima Chiari,Shiohira Toshiharu,Shimizu Ari,Tsuruta Yuki,Amemiya Nobuyuki,Ogawa Tetsuya,Uchida Keiko,Tsuchiya Ken,Nitta Kosaku

Publisher

S. Karger AG

Subject

Nephrology,General Medicine

Reference26 articles.

1. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome

2. Cyclosporine-A-induced nephrotoxicity in children with minimal-change nephrotic syndrome: long-term treatment up to 10 years

3. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

4. Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

5. Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the treatment of IgA nephropathy with biological agents;Chronic Diseases and Translational Medicine;2023-12-10

2. Role of telitacicept in the treatment of IgA nephropathy;European Journal of Medical Research;2023-09-22

3. Membranoproliferative Glomerulonephritis;Evidence‐Based Nephrology;2022-11-18

4. Membranoproliferative Glomerulonephritis and C3 Glomerulopathy in Children;Pediatric Nephrology;2022

5. Treatment of Membranoproliferative Glomerulonephritis with Traditional Chinese Medicine and Rituximab: A Case Report;Integrative Medicine in Nephrology and Andrology;2021-12